Genome packaging in influenza A virus. by Hutchinson, E, von Kirchbach, J, Gog, JR, Digard, P

Mutational analysis of cis-acting RNA signals in segment 7 of influenza A virus. by Hutchinson, E, Curran, MD, Read, E, Gog, JR, Digard, P

PA-X antagonises MAVS-dependent accumulation of early type I interferon messenger RNAs during influenza A virus infection by Rigby, RE, Wise, HM, Smith, N, Digard, P, Rehwinkel, J

Characterisation of influenza A viruses with mutations in segment 5 packaging signals. by Hutchinson, E, Wise, H, Kudryavtseva, K, Curran, MD, Digard, P

Nuclear dynamics of influenza A virus ribonucleoproteins revealed by live-cell imaging studies. by Loucaides, E, von Kirchbach, J, Foeglein, A, Sharps, J, Fodor, E, Digard, P

Studies of an influenza A virus temperature-sensitive mutant identify a late role for NP in the formation of infectious virions. by Noton, S, Simpson-Holley, M, Medcalf, E, Wise, H, Hutchinson, E, McCauley, J, Digard, P

Vaccinia virus uses retromer-independent cellular retrograde transport pathways to facilitate the wrapping of intracellular mature virions during virus morphogenesis by Harrison, K, Haga, IR, Jowers, T, Jasim, S, Cintrat, J-C, Gillet, D, Schmitt-John, T, Digard, P, Beard, PM

Elevation of CpG frequencies in influenza A genome attenuates pathogenicity but enhances host response to infection. by Gaunt, E, Wise, H, Zhang, H, Lee, L, Atkinson, N, Nicol, M, Highton, A, Klenerman, P, Beard, P, Dutia, B, Digard, P, Simmonds, P

An innate defense peptide BPIFA1/SPLUNC1 restricts influenza A virus infection by Akram, K, Moyo, N, Leeming, G, Bingle, L, Jasim, S, Hussain, S, Schorlemmer, A, Kipar, A, Digard, P, Tripp, R, Shohet, R, Bingle, C, Stewart, J

Identification of a novel splice variant form of the influenza A virus M2 ion channel with an antigenically distinct ectodomain. by Wise, H, Hutchinson, E, Jagger, B, Stuart, A, Kang, Z, Robb, N, Schwartzman, L, Kash, J, Fodor, E, Firth, A, Gog, JR, Taubenberger, J, Digard, P

IFITM3 restricts the morbidity and mortality associated with influenza by Everitt, A, Clare, S, Pertel, T, John, S, Wash, R, Smith, SE, Chin, C, Feeley, E, Sims, J, Adams, D, Wise, H, Kane, L, Goulding, D, Digard, P, Anttila, V, Baillie, J, Walsh, T, Hume, D, Palotie, A, Xue, Y, Colonna, V, Tyler-Smith, C, Dunning, J, Gordon, S, Everingham, K

The P323L substitution in the SARS-CoV-2 polymerase (NSP12) confers a selective advantage during infection by Goldswain, H, Dong, X, Penrice-Randal, R, Alruwaili, M, Shawli, GT, Prince, T, Williamson, MK, Raghwani, J, Randle, N, Jones, B, Donovan-Banfield, I, Salguero, FJ, Tree, JA, Hall, Y, Hartley, C, Erdmann, M, Bazire, J, Jearanaiwitayakul, T, Semple, MG, Openshaw, PJM, Baillie, JK, Emmett, SR, Digard, P, Matthews, DA, Turtle, L, Darby, AC, Davidson, AD, Carroll, MW, Hiscox, JA, Carson, G, Dunning, J, Horby, PW, Klenerman, P, Mentzer, AJ, Merson, L, Sigfrid, L, Stuart, D, Angus, B